Which targeted therapies are used to treat stage IV non–small cell lung cancer (NSCLC)?

Updated: Jul 15, 2021
  • Author: Winston W Tan, MD, FACP; Chief Editor: Nagla Abdel Karim, MD, PhD  more...
  • Print

American Society of Clinical Oncology (ASCO) guidelines on systemic therapy for stage IV disease provide separate recommendations for tumors with and without genetic alterations that allow targeted therapy. See Guidelines/Treatment of Stage IV Disease. [220, 221, 222]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!